Cargando…
Recurrent ovarian cancer in the era of poly-ADP ribose polymerase inhibitors: time to re-assess established clinical practices
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100608/ https://www.ncbi.nlm.nih.gov/pubmed/33930658 http://dx.doi.org/10.1016/j.esmoop.2021.100135 |
| _version_ | 1783688823809507328 |
|---|---|
| author | Bartoletti, M. Cecere, S.C. Musacchio, L. Sorio, R. Puglisi, F. Pignata, S. |
| author_facet | Bartoletti, M. Cecere, S.C. Musacchio, L. Sorio, R. Puglisi, F. Pignata, S. |
| author_sort | Bartoletti, M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8100608 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81006082021-05-14 Recurrent ovarian cancer in the era of poly-ADP ribose polymerase inhibitors: time to re-assess established clinical practices Bartoletti, M. Cecere, S.C. Musacchio, L. Sorio, R. Puglisi, F. Pignata, S. ESMO Open Editorial Elsevier 2021-04-27 /pmc/articles/PMC8100608/ /pubmed/33930658 http://dx.doi.org/10.1016/j.esmoop.2021.100135 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Editorial Bartoletti, M. Cecere, S.C. Musacchio, L. Sorio, R. Puglisi, F. Pignata, S. Recurrent ovarian cancer in the era of poly-ADP ribose polymerase inhibitors: time to re-assess established clinical practices |
| title | Recurrent ovarian cancer in the era of poly-ADP ribose polymerase inhibitors: time to re-assess established clinical practices |
| title_full | Recurrent ovarian cancer in the era of poly-ADP ribose polymerase inhibitors: time to re-assess established clinical practices |
| title_fullStr | Recurrent ovarian cancer in the era of poly-ADP ribose polymerase inhibitors: time to re-assess established clinical practices |
| title_full_unstemmed | Recurrent ovarian cancer in the era of poly-ADP ribose polymerase inhibitors: time to re-assess established clinical practices |
| title_short | Recurrent ovarian cancer in the era of poly-ADP ribose polymerase inhibitors: time to re-assess established clinical practices |
| title_sort | recurrent ovarian cancer in the era of poly-adp ribose polymerase inhibitors: time to re-assess established clinical practices |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100608/ https://www.ncbi.nlm.nih.gov/pubmed/33930658 http://dx.doi.org/10.1016/j.esmoop.2021.100135 |
| work_keys_str_mv | AT bartolettim recurrentovariancancerintheeraofpolyadpribosepolymeraseinhibitorstimetoreassessestablishedclinicalpractices AT ceceresc recurrentovariancancerintheeraofpolyadpribosepolymeraseinhibitorstimetoreassessestablishedclinicalpractices AT musacchiol recurrentovariancancerintheeraofpolyadpribosepolymeraseinhibitorstimetoreassessestablishedclinicalpractices AT sorior recurrentovariancancerintheeraofpolyadpribosepolymeraseinhibitorstimetoreassessestablishedclinicalpractices AT puglisif recurrentovariancancerintheeraofpolyadpribosepolymeraseinhibitorstimetoreassessestablishedclinicalpractices AT pignatas recurrentovariancancerintheeraofpolyadpribosepolymeraseinhibitorstimetoreassessestablishedclinicalpractices |